These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38387912)
1. [Mechanism and Clinical Significance of Wang YR; Ma YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):138-145. PubMed ID: 38387912 [TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study. Bong IP; Ng CC; Fakiruddin SK; Lim MN; Zakaria Z Bosn J Basic Med Sci; 2016 Nov; 16(4):268-275. PubMed ID: 27754828 [TBL] [Abstract][Full Text] [Related]
3. [Effect of TRIM31 Gene Silencing on the Proliferation and Apoptosis of U266 Cells and Its Mechanism]. Long XX; Wen F; Chen Q; Cao YX; Huang XQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):805-811. PubMed ID: 34105476 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity. Que W; Chen J; Chuang M; Jiang D APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676 [TBL] [Abstract][Full Text] [Related]
5. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines. Zeissig MN; Hewett DR; Mrozik KM; Panagopoulos V; Wallington-Gates CT; Spencer A; Dold SM; Engelhardt M; Vandyke K; Zannettino ACW Leuk Res; 2024 Apr; 139():107469. PubMed ID: 38479337 [TBL] [Abstract][Full Text] [Related]
6. Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma. Mimura N; Fulciniti M; Gorgun G; Tai YT; Cirstea D; Santo L; Hu Y; Fabre C; Minami J; Ohguchi H; Kiziltepe T; Ikeda H; Kawano Y; French M; Blumenthal M; Tam V; Kertesz NL; Malyankar UM; Hokenson M; Pham T; Zeng Q; Patterson JB; Richardson PG; Munshi NC; Anderson KC Blood; 2012 Jun; 119(24):5772-81. PubMed ID: 22538852 [TBL] [Abstract][Full Text] [Related]
7. [Expression and Clinical Significance of NAMPT in Bone Marrow of Patients with Multiple Myeloma]. Wang YR; Ma YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1739-1744. PubMed ID: 38071054 [TBL] [Abstract][Full Text] [Related]
8. [Expression of Wang YR; Ma YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):769-776. PubMed ID: 37356938 [TBL] [Abstract][Full Text] [Related]
9. [Atractylenolide I Can Induce Apoptosis of U266 Cells and Enhance Bortezomib Effect]. Mai ZX; Yu TQ; Fan TT Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):177-184. PubMed ID: 32027273 [TBL] [Abstract][Full Text] [Related]
10. [Study of the effects Tian Y; Li LH; Yang GZ; Chen WM Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):976-981. PubMed ID: 27995884 [TBL] [Abstract][Full Text] [Related]
11. [Expression of Blimp1、ATF4 and CHOP in Multiple Myeloma Cells and Effect of Aspirin on Their Expression]. Liu HC; Xiong C; Geng J; Liu JW; Ren ZZ; Li J; Pei L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):165-170. PubMed ID: 32027271 [TBL] [Abstract][Full Text] [Related]
12. Effects of Histone Deacetylase Inhibitor Panobinostat (LBH589) on Bone Marrow Mononuclear Cells of Relapsed or Refractory Multiple Myeloma Patients and Its Mechanisms. Ma Y; Liu W; Zhang L; Jia G Med Sci Monit; 2017 Oct; 23():5150-5157. PubMed ID: 29080899 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of Sprouty homolog 2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells. Wang JH; Zhou WW; Cheng ST; Liu BX; Liu FR; Song JQ Mol Med Rep; 2015 Aug; 12(2):1810-6. PubMed ID: 25825239 [TBL] [Abstract][Full Text] [Related]
14. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma. Wang WQ; Zhao XY; Wang HY; Liang Y J Zhejiang Univ Sci B; 2008 Jun; 9(6):441-7. PubMed ID: 18543396 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Ras Homolog C/Rho-Associated Coiled-Protein Kinase (Rho/ROCK) Signaling Pathways on Proliferation and Apoptosis of Human Myeloma Cells. Feng X; Zhang L; Nie S; Zhuang L; Wang W; Huang J; Yan X; Meng F Med Sci Monit; 2019 Oct; 25():7605-7616. PubMed ID: 31599230 [TBL] [Abstract][Full Text] [Related]
16. Silencing of augmenter of liver regeneration inhibited cell proliferation and triggered apoptosis in U266 human multiple myeloma cells. Zeng HQ; Luo Y; Lou SF; Liu Q; Zhang L; Deng JC Braz J Med Biol Res; 2017 Aug; 50(10):e6139. PubMed ID: 28876364 [TBL] [Abstract][Full Text] [Related]
17. Bortezomib promotes apoptosis of multiple myeloma cells by regulating HSP27. Li J; Zhang X; Shen J; Guo J; Wang X; Liu J Mol Med Rep; 2019 Sep; 20(3):2410-2418. PubMed ID: 31322176 [TBL] [Abstract][Full Text] [Related]
18. Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines. Barbosa RSS; Dantonio PM; Guimarães T; de Oliveira MB; Fook Alves VL; Sandes AF; Fernando RC; Colleoni GWB Biochem Biophys Res Commun; 2019 Nov; 519(3):597-604. PubMed ID: 31540690 [TBL] [Abstract][Full Text] [Related]
19. [Knockdown of nuclear protein 1 (NUPR1) gene inhibits proliferation and promotes apoptosis of human multiple myeloma U266 cells]. Zeng C; Yi B; Li X; Chen J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1240-1246. PubMed ID: 29089084 [TBL] [Abstract][Full Text] [Related]
20. [Effects of PSMB5 on proliferation and bortezomib chemo-resistance in human myeloma cells and its related molecular mechanisms]. Mo HM; Wu QY; Han DY; Liu R; Ma X; Zhou P; Xu KL Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1053-1057. PubMed ID: 29365400 [No Abstract] [Full Text] [Related] [Next] [New Search]